Dosage form:
Lozenges
Composition:
lysozyme hydrochloride 20 mg pyridoxine hydrochloride 10 mg Excipients: lactose monohydrate, tragacanth, magnesium stearate, sodium saccharin, vanillin.
Pharmacodynamics:
Antiseptic for topical use in ENT practice and dentistry. Lysozyme is an enzyme of protein nature (mucolytic enzyme mucopeptide-N-acetylmuramyl hydrolase) and is used as an antiseptic (causes lysis of the cell membrane of gram-positive and gram-negative bacteria and fungi), also has antiviral activity. Pyridoxine promotes the regeneration of the oral mucosa and has an anti-aphthous effect. Pharmacokinetics No pharmacokinetic data available
Side effects:
Rarely: allergic reactions.
The drug is well tolerated. Sales Features
Special conditions:
In case of an allergic reaction, the use of the drug must be discontinued.
Indications:
Prevention and treatment of infectious and inflammatory diseases of the oral mucosa,
gums and larynx:
- stomatitis;
- gingivitis;
- herpetic lesions of the oral mucosa;
- erosion of the oral mucosa of various etiologies; - catarrhal phenomena of the upper respiratory tract.
Contraindications:
hypersensitivity to the drug components Drug interaction When combined, Lizobact enhances the therapeutic effect of antibiotics and nitrofurans (including penicillin, chloramphenicol, nitrofurantoin)
Dosage:
The drug is prescribed for 2 tablets 3-4. The course of treatment is 8 days. If necessary, the course of treatment can be extended. Lizobact tablets should be absorbed slowly, the dissolved mass must be retained in the oral cavity as long as possible. Do not swallow tablets.
Overdose:
Data on an overdose of the drug Lizobact not provided.
